Your browser doesn't support javascript.
loading
Novel Nano-Drug Delivery System for Brain Tumor Treatment.
Qiu, Ziyi; Yu, Zhenhua; Xu, Ting; Wang, Liuyou; Meng, Nanxin; Jin, Huawei; Xu, Bingzhe.
Afiliación
  • Qiu Z; School of Biomedical Engineering, Shenzhen Campus of Sun Yat-Sen University, Shenzhen 518107, China.
  • Yu Z; School of Biomedical Engineering, Sun Yat-Sen University, Guangzhou 510275, China.
  • Xu T; Sun Yat-Sen University First Affiliated Hospital, Guangzhou 510060, China.
  • Wang L; School of Biomedical Engineering, Shenzhen Campus of Sun Yat-Sen University, Shenzhen 518107, China.
  • Meng N; School of Biomedical Engineering, Sun Yat-Sen University, Guangzhou 510275, China.
  • Jin H; School of Biomedical Engineering, Shenzhen Campus of Sun Yat-Sen University, Shenzhen 518107, China.
  • Xu B; School of Biomedical Engineering, Sun Yat-Sen University, Guangzhou 510275, China.
Cells ; 11(23)2022 Nov 24.
Article en En | MEDLINE | ID: mdl-36497021
ABSTRACT
As the most dangerous tumors, brain tumors are usually treated with surgical removal, radiation therapy, and chemotherapy. However, due to the aggressive growth of gliomas and their resistance to conventional chemoradiotherapy, it is difficult to cure brain tumors by conventional means. In addition, the higher dose requirement of chemotherapeutic drugs caused by the blood-brain barrier (BBB) and the untargeted nature of the drug inevitably leads to low efficacy and systemic toxicity of chemotherapy. In recent years, nanodrug carriers have attracted extensive attention because of their superior drug transport capacity and easy-to-control properties. This review systematically summarizes the major strategies of novel nano-drug delivery systems for the treatment of brain tumors in recent years that cross the BBB and enhance brain targeting, and compares the advantages and disadvantages of several strategies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioma / Antineoplásicos Límite: Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Glioma / Antineoplásicos Límite: Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: China